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Abstract
Background: Obesity is linked to increased left ventricular mass, an independent predictor of
mortality. As a result of this, understanding the determinants of left ventricular mass in the setting
of obesity has both therapeutic and prognostic implications. Using cardiovascular magnetic
resonance our goal was to elucidate the main predictors of left ventricular mass in severely obese
subjects free of additional cardiovascular risk factors.
Methods: 38 obese (BMI 37.8 ± 6.9 kg/m2) and 16 normal weight controls subjects, (BMI 21.7 ±
1.8 kg/m2), all without cardiovascular risk factors, underwent cardiovascular magnetic resonance
imaging to assess left ventricular mass, left ventricular volumes and visceral fat mass. Left ventricular
mass was then compared to serum and anthropometric markers of obesity linked to left ventricular
mass, i.e. height, age, blood pressure, total fat mass, visceral fat mass, lean mass, serum leptin and
fasting insulin level.
Results: As expected, obesity was associated with significantly increased left ventricular mass (126
± 27 vs 90 ± 20 g; p < 0.001). Stepwise multiple regression analysis showed that over 75% of the
cross sectional variation in left ventricular mass can be explained by lean body mass (β = 0.51, p <
0.001), LV stroke volume (β = 0.31 p = 0.001) and abdominal visceral fat mass (β = 0.20, p = 0.02),
all of which showed highly significant independent associations with left ventricular mass (overall
R2 = 0.77).
Conclusion: The left ventricular hypertrophic response to obesity in the absence of additional
cardiovascular risk factors is mainly attributable to increases in lean body mass, LV stroke volume
and visceral fat mass. In view of the well documented link between obesity, left ventricular
hypertrophy and mortality, these findings have potentially important prognostic and therapeutic
implications for primary and secondary prevention.
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Background
Left ventricular hypertrophy is one of the characteristic
cardiac adaptations to obesity. [1-3] As there is now a
growing body of literature that has demonstrated a strong
relationship between left ventricular hypertrophy and all
cause mortality, [4-6] and given the increasing prevalence
of obesity, and the fact that obesity is associated with an
increased risk of death [7], understanding the ways in
which obesity modulates cardiovascular risk is of increas-
ing clinical importance. Furthermore, identification of the
determinants of left ventricular mass in obesity has poten-
tially important implications for prognosis and therapeu-
tic intervention aimed at primary and secondary
prevention.
The mechanisms underlying left ventricular hypertrophy
have been the focus of many investigations and large pop-
ulation based studies have demonstrated that multiple
clinical parameters are associated with left ventricular
mass, such as age, systolic blood pressure, body size, and
both visceral and free fat mass. [8] However, most of these
studies have relied on echocardiography, a difficult tech-
nique in obesity due to thoracic fat deposits limiting
acoustic windows. In addition to this, the majority of pre-
vious studies have investigated subjects with the obesity
related co-morbidities of hypertension, diabetes and
hypercholesterolaemia, factors that are known to exert
independent effects on the cardiovascular system.
The excess fat mass associated with obesity is known to
increase metabolic demand and, thus, both cardiac out-
put and total blood volume are elevated in obesity. These
circulatory changes cause left ventricular geometric
remodelling in the form of cavity dilatation, a structural
change commonly seen in obesity, which is then thought
to lead to a compensatory left ventricular hypertrophic
response in response to increased wall stress. [1,9-11]
In addition to this, advances in the understanding of hor-
monal changes in obesity have highlighted several alter-
native mechanisms. Increased visceral and subcutaneous
adiposity is known to cause higher levels of serum leptin,
the hallmark of human obesity, and hyperinsulinaemia,
both of which have been linked to ventricular hypertro-
phy in humans and in animal models. [12-15]
Or aim was to identify the determinants of left ventricular
mass in a population of otherwise healthy obese subjects,
free from identifiable cardiovascular risk factors and co-
morbidity. In order to achieve this, we used cardiovascular
magnetic resonance (CMR), which yields accurate and
highly reproducible assessment of left ventricular mass,
regardless of the amount of chest wall fat, [16] and related
these measures to age, height, body surface area, visceral
fat mass, total fat mass, lean body mass, leptin, insulin, C-
reactive protein, end-diastolic volume, stroke-volume and
ascending aortic size and distensibility, all of which have
been proposed as independent predictors of left ventricu-
lar mass.[8,14,17]
Methods
Ethics and Study Cohort
The study was approved by the local ethics committee,
and informed written consent was obtained from each
patient.
In this study thirty eight healthy obese subjects (BMI > 30
kg/m2, 9 male, 29 female) and sixteen normal weight sub-
jects (BMI 18.5 – 24.9 kg/m25 male, 11 female) were
included into the study. In order to prevent the con-
founder of ethnicity all recruited subjects were Caucasian.
All subjects were screened for the presence of identifiable
cardiac risk factors and excluded if they had a history of
cardiovascular disease, hypertension, diabetes, current
smoking, or use of cardiac medications. All subjects had a
normal 12 lead electrocardiogram and were normotensive
at the time of scanning (averaged over three supine meas-
ures taken within 10 minutes) with no historical evidence
of hypertension. Subjects were excluded if they had either
an elevated fasting glucose level (≥ 6.7 mmol) or a fasting
total cholesterol level ≥ 6.5 mmol, a history of coronary
artery disease, or of cardiac chest pain or valvular heart
disease. All patients were excluded if they had clinical or
historical evidence of obstructive sleep apnoea. All sub-
jects were limited to three thirty minute sessions of sweat
producing exercise per week, and excluded if physical
activity exceeded this level.
Blood tests
Fasting blood tests for glucose, cholesterol, leptin and
insulin, were taken on the day of the scan. Patients were
asked to be fasted for at least 8 hours. An estimate of insu-
lin resistance was calculated using the HOMA-IR equation
(fasting insulin (μU/ml) × fasting glucose (mmol/l)]/
22.5)[18,19].
Body Composition analysis
Bio-electrical impedance was used to determine total
body fat mass, and lean body mass using Bodystat ©1500
analyser. The use of Bioimpednace analysis has become
routine in clinical research investigating body composi-
tion analysis. Although not the gold standard for analysis
of body composition it has been proved to have good cor-
relation with DEXA assessments in multiple studies. [20-
22] Bio-electrical impedance analysis measures the
impedance or opposition to the flow of an electric current
through the body fluids contained mainly in the lean and
fat tissue. Impedance is low in lean tissue, where intracel-
lular and extracellular fluid and electrolytes are primarily
contained, but high in fat tissue. Impedance is thus pro-Journal of Cardiovascular Magnetic Resonance 2009, 11:9 http://www.jcmr-online.com/content/11/1/9
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portional to body water volume. In practice, a small 400
uA current at 50 kHz, was passed between electrodes span-
ning the body to provide a measure of impedance. The
Bodystat ©1500 then converted measured impedance to a
corresponding estimate of TBW. Lean body mass is then
calculated from this estimate using an assumed hydration
fraction for lean tissue. Fat mass is calculated as the differ-
ence between body weight and lean body mass. For the
calculation of the waist:hip ratio the average of three waist
measurements was recorded at a) the level of the umbili-
cus, and b) the level of the greater trochanter of the femur.
CMR
Cardiac and Aortic Imaging
All CMR scans for the assessment of left ventricular mass,
volumes, ejection fraction and aortic distensibility were
performed on a 1.5 Tesla MR system (Siemens Medical
Solutions, Erlangen, Germany) as previously
described.[23] All imaging was prospectively cardiac gated
with a precordial four lead ECG and acquired during end
expiratory breathold. Cardiac cine images were acquired
using a steady state free precession (SSFP) sequence with
an echo time (TE) of 1.5 ms, a repetition time (TR) of 3.0
ms, temporal resolution 47.84 ms and a flip angle of 60°.
Following localisation images, an SSFP cine short axis
stack of contiguous images was obtained with a slice
thickness of 7 mm and an interslice gap of 3 mm, as pre-
viously described. [24-26] Ascending aortic distensibility
was determined from cine images taken at the level of the
pulmonary artery as previously described. [25] Indices of
aortic function were assessed using a 25 frame retrogated
SSFP cine sequence with the following parameters: TR 42
ms, TE 1.4 ms, FOVread 380 mm, in plane resolution 1.97
mm, slice thickness 7 mm.
Visceral fat mass
A single breathold, contiguous 5 slice, T1 weighted Turbo
Spin Echo sequence centred around the vertebral body of
L5 (turbo factor 5, echo time TE 12 ms, TR 200 ms, slice
thickness 10 mm) was modified so that the sequence
served to suppress predominantly the water signal[27].
Transverse slices were then manually contoured to pro-
vide a visceral fat volume.
Data Analysis
Image analysis for left ventricular volumes and mass was
performed using Siemens analytical software (ARGUS©) as
described [24]. The short axis stack was analysed manu-
ally contouring the endocardial borders from base to apex
at end-diastole and end-systole. The epicardial border was
contoured at end-diastole to yield myocardial mass. Left
ventricular mass (g) were calculated as the epicardial vol-
ume minus the endocardial volume multiplied by 1.05
(specific gravity of myocardium). Cardiac output (l/min)
was calculated as left ventricular stroke volume (ml) ×
heart rate (bpm).
Statistical Analysis
All statistical analysis was performed using SPSS statistical
software (version 15.0; SPSS Inc., Chicago, Ill., USA). Data
are expressed as means ± SD unless otherwise stated. All
continuous variables were normally distributed. Differ-
ences between groups were assessed by Student's unpaired
t test. Obese and normal weight groups were matched as
groups, not as pairs. A probability value of p < 0.05 was
considered significant and two-tailed p values were used
for all statistics.
To assess the major determinants of left ventricular mass,
a stepwise multiple linear regression model was per-
formed. This multivariate model consisted of left ventricu-
lar mass as dependent variable and of independent
variables that had a significant relation with left ventricu-
lar mass in the simple linear regression analysis.
Results
Baseline Group Characteristics
Normal controls and obese subjects were well matched
for age, height, systolic blood pressure, diastolic blood
pressure, fasting glucose and fasting total cholesterol, with
no significant differences between obese and normal
weight individuals. Waist hip ratio, total fat mass, visceral
fat mass and lean mass were all higher in the obese group
(Table 1 and 2, Figure 1). Serum leptin was over 9 times
higher in the obese group. Fasting insulin and HOMA-IR
were also higher in the obese cohort with the average still
in the insulin sensitive range. C- reactive protein levels
were increased more than 10-fold in the obese group
(Tables 1 and 2).
Left Ventricular and Aortic Characteristics
Left ventricular mass and end-diastolic volume were both
larger in the obese group when compared to the normal
weight group. End-systolic volume, stroke volume and
cardiac output were also elevated in obesity. Left ventricu-
lar ejection fraction was similar in normal weight and
obese subjects (Table 3). Aortic distensibility in the
ascending aorta was similar in the normal and obese
group (4.56 ± 2.0 vs 4.63 ± 2.0 mmHg-1 × 10-3, p = 0.90)
Relationship between Serum Markers of Obesity and Left 
Ventricular Mass
The associations of individual serum markers of obesity
with left ventricular mass was determined using simple
linear regression, with left ventricular mass as the depend-
ent variable. Both leptin and insulin had a significant pos-
itive relationship with left ventricular mass. C-reactive
protein and fasting serum glucose level were not related to
left ventricular mass.Journal of Cardiovascular Magnetic Resonance 2009, 11:9 http://www.jcmr-online.com/content/11/1/9
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Relationship between Anthropometric Data and Left 
Ventricular Mass
On simple linear regression, total fat mass, visceral fat
mass, lean mass, waist hip ratio and BMI all showed a sig-
nificant positive relationship with left ventricular mass. In
addition to this both height and age had positive relation-
ships with left ventricular mass. In this normotensive
cohort, neither systolic nor diastolic blood pressure were
related to left ventricular mass (Table 4).
Relationship between Left Ventricular Function, Aortic 
Function and Left Ventricular Mass
On simple linear regression, left ventricular end-diastolic
volume, end-systolic volume, stroke volume and cardiac
output were all associated with left ventricular mass. Nei-
ther left ventricular ejection fraction nor ascending aortic
distensibility were related to left ventricular mass (Table
4)
Independent Predictors of Left Ventricular Mass
To assess the major determinants of left ventricular mass,
a stepwise multiple linear regression analysis of all data
was performed. The multivariate model consisted of left
ventricular mass as the dependent variable and of inde-
pendent variables that had the most significant relation-
ships with left ventricular mass in the simple linear
regression analysis (visceral fat mass, total fat mass, lean
body mass, height, age, insulin, and stroke volume, BMI).
Multivariate analysis of left ventricular mass revealed lean
body mass (β = 0.51, p < 0.001), left ventricular stroke
volume (β = 0.31 p = 0.001) and visceral fat mass (β =
0.20, p = 0.02) as the main independent predictors of left
ventricular mass (overall R2 = 0.77, Figure 2).
Visceral Fat Mass Images from A) Obese (BMI 37.3 kg/m2)  and B) Normal Weight Subject (BMI 19.5 kg/m2) Figure 1
Visceral Fat Mass Images from A) Obese (BMI 37.3 
kg/m2) and B) Normal Weight Subject (BMI 19.5 kg/
m2).
 
Table 1: Anthropometric results for the study population
Normal Weight Subjects N = 16 Obese Subjects N = 38 p value
Body Mass Index (kg/m2) 21.7 ± 1.8 37.8 ± 6.9 <0.001
Weight (kg) 61 ± 9 105 ± 18 <0.001
Percentage Excess Weight (%) ______ 51 ± 28
Systolic Blood Pressure (mmHg) 114 ± 9 117 ± 11 0.34
Diastolic Blood Pressure (mmHg) 72 ± 8 75 ± 8 0.21
Waist Hip Ratio 0.81 ± 0.08 0.92 ± 0.08 <0.001
Total Fat Mass (kg) 19 ± 10 47 ± 16 <0.001
Visceral Fat Mass (dm3) 243 ± 123 667 ± 276 <0.001
Lean Mass (kg) 46 ± 8 57 ± 9 <0.001
Age (yrs) 47 ± 10 42 ± 10 0.09
Height (m) 1.68 ± 0.06 1.67 ± 0.08 0.58Journal of Cardiovascular Magnetic Resonance 2009, 11:9 http://www.jcmr-online.com/content/11/1/9
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Discussion
In this study, we are the first group to use CMR to investi-
gate the determinants of left ventricular mass in a severely
obese population without additional co-morbidity and
no other identifiable cardiovascular risk factors. In agree-
ment with previous studies, we have again shown that
obesity is associated with elevated left ventricular mass,
cavity dilatation and increased cardiac output. [1] As a
novel finding, we demonstrate that lean body mass, vis-
ceral fat mass and stroke volume are independent predic-
tors of absolute left ventricular mass in this cohort.
The various determinants of left ventricular hypertrophy
in the general population has been the subject of multiple
research studies, but no study to date has investigated
obesity without the confounders of obesity related comor-
bidites. Such studies have highlighted age, height, sys-
temic arterial hypertension, and body size as the main
predictors of left ventricular hyperrtophy. [8,28] In the
setting of obesity accompanied by co-morbidities, insulin
resistance, abdominal adiposity, systemic arterial hyper-
tension, and lean mass have previously been shown to be
the main predictors of left ventricular mass. [29-31] In
order to dissociate the effects of obesity per se from the co-
morbidities of obesity, which are known to exert inde-
pendent effects on the myocardium, we now investigated
obese subjects without hypertension or pathological insu-
lin resistance.
Lean Body Mass
The effect of increased lean body mass representing all
non-adipose tissue, in determining left ventricular mass in
an obese population with co-morbidities, has been estab-
lished, with lean mass being more associated with left
ventricular mass than total fat mass. [8,31] Here, we show,
for the first time, that the major determinant of left ven-
tricular mass in an obese population without additional
cardiovascular risk factors and co-morbidity is also lean
body mass. This could be explained by the fact increased
body size, as a result of increased fat mass, would be
expected to result in an associated increase in skeletal
muscle mass in order to compensate for the additional
physical demand of increased weight. As lean mass is
responsible for the majority of the metabolic activity of
the body and is one of the principle determinants of car-
diac output, the strong association between increased left
ventricular mass and increased lean mass is not surprising.
In addition to this, both left ventricular mass and lean
body mass would also be expected to vary with intrinsic
differences in body size i.e. height. In order to account for
this variation in lean mass that occurs with intrinsic body
size differences, which is not linked to increased cardio-
vascular risk, we investigated the association between lean
body mass indexed to height and left ventricular mass.
Interestingly, when lean mass was indexed to height the
relationship with left ventricular mass remains as strong
as that with absolute lean body mass (Table 4). This sug-
gests not only that the increased lean mass seen here was
not due to inherent differences in body size, but also that
Table 2: Fasting blood results for the study population
Normal Weight Subjects N = 16 Obese Subjects N = 38 p value
Fasting Blood Glucose (mmol/l) 5.0 ± 0.42 5.2 ± 0.6 0.223
Fasting Total Cholesterol (mmol/l) 5.1 ± 0.8 5.0 ± 0.8 0.66
Fasting HDL Cholesterol (mmol/l) 1.7 ± 0.4 1.3 ± 0.3 <0.01
Fasting Insulin (μm/l) 3.5 ± 5.8 11.1 ± 10.0 <0.01
Fasting Leptin (ng/l) 13 ± 18 119 ± 71 <0.001
HOMA-IR 0.82 ± 1.4 2.66 ± 2.58 0.01
C-Reactive Protein (mg/l) 0.2 ± 0.8 1.9 ± 3.2 <0.01
Table 3: Left Ventricular Characteristics for the Study Population
Obese Subjects N = 38 Normal Weight Subjects N = 16 p value
Left Ventricular Mass (g) 126 ± 27 90 ± 20 <0.001
Left Ventricular End-diastolic Volume (ml) 146 ± 20 116 ± 22 <0.001
Left Ventricular End-systolic
Volume (ml)
45 ± 11 37 ± 11 <0.001
Left Ventricular Stroke
Volume (ml)
101 ± 15 79 ± 16 <0.001
Left Ventricular Ejection Fraction (%) 69 ± 5 68 ± 6 0.66
Cardiac Output (ml) 6.6 ± 1.3 4.8 ± 1.3 <0.001Journal of Cardiovascular Magnetic Resonance 2009, 11:9 http://www.jcmr-online.com/content/11/1/9
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the left ventricular mass increases seen here are more
likely related to increases in lean mass that occur second-
ary to obesity.
Visceral Fat Mass
Visceral fat has been positively correlated with left ven-
tricular mass in normotensive obese subjects and adipose
tissue is one of main sources of the hormonal factors
increasing left ventricular mass via non-haemodynamic
mechanisms. [32]
Here again we show a strong positive correlation between
visceral fat mass, as assessed by magnetic resonance imag-
ing, and left ventricular mass. As the amount of intra-
abdominal fat is now considered to be a risk factor for car-
diovascular disease, establishing how visceral fat affects
left ventricular characteristics is of increasing importance.
Elevated visceral fat mass has been linked to subacute
inflammation and hyperinsulinaemia, both of which
have been previously shown to be correlated with left ven-
tricular mass. [33] Hyperinsulinaemia, as a result of insu-
lin resistance, is a potential explanation for the
association between increased visceral fat mass and ven-
tricular hypertrophy seen here. Hyperinsulinaemia has
been linked to ventricular hypertrophy in obesity directly
via the binding of insulin to myocardial insulin-like
growth factor 1 receptors.[34] In this study, although
insulin was seen to be a related to left ventricular mass on
simple linear regression, it was not seen to be an inde-
pendent predictor of left ventricular mass on multiple
regression analysis. This points to the fact that visceral fat
is acting through the composite of multiple mechanisms
including hyperinsulinaemia, insulin resistance, inflam-
mation and hyperleptinaemia, all of which in this study
have smaller individual correlations with left ventricular
mass.
Stroke Volume
Left ventricular stroke volume has been shown to be a
major determinant of left ventricular mass in various
patient groups including hypertensive and overweight
subjects [35,36]. In this study, we have shown that stroke
volume is a strong predictor of left ventricular mass in
obese individuals without associated hypertension. It is
thought that the hypertrophic response of the left ventri-
cle in obesity is, at least in part, secondary to increased
wall stress imposed by cavity dilatation and stroke volume
increases. [10,11] Here, we have shown that both end-
diastolic volume and stroke volume are strongly associ-
ated with left ventricular mass on simple linear regression,
and that stroke volume is an independent predictor of left
ventricular mass in this group of patients. However, given
the fact that in the setting of eccentric hypertrophy, the
pattern seen here in obesity, increased end diastolic vol-
ume is inexorably linked to increased left ventricular mass
it becomes unsurprising that as stroke volume is deter-
mined by end-diastolic volume, stroke volume itself is a
major determinant of left ventricular mass.
Hormonal and Inflammatory Changes
This study has confirmed the previous findings demon-
strating positive correlations between serum marker of
obesity i.e leptin and insulin and left ventricular mass
changes. [12-15] However, although both hormones are
Table 4: Linear Regression Analysis for Left Ventricular Mass
R2 β F p value
Body Mass Index (kg/m2) .263 .51 18.5 <0.001
Age (yrs) .112 .34 6.6 0.013
Height (m) .196 .44 12.7 0.001
Systolic Blood Pressure (mmHg) .050 .22 2.7 0.11
Diastolic Blood Pressure (mmHg) .052 .23 2.8 .09
Waist Hip Ratio .292 .54 21.4 <0.001
Total Fat Mass (kg) .152 .39 9.3 0.004
Visceral Fat Mass (dm3) .388 .62 33.0 <0.001
Lean Mass (kg) .701 .84 121.8 <0.001
Fasting Blood Glucose (mmol/l) .087 .29 4.7 0.04
Fasting Insulin (μm/l) .174 .42 10.9 0.02
Fasting Leptin (ng/l) .079 .28 4.4 0.04
C-Reactive Protein (mg/l) .075 .27 3.6 0.07
Left Ventricular End-diastolic Volume (ml) .509 .71 53.2 <0.001
Left Ventricular End-systolic
Volume (ml)
.153 .39 9.4 0.003
Left Ventricular Stroke
Volume (ml)
.531 .73 58.9 <0.001
Cardiac Output (ml) .244 .49 16.7 <0.001
Ascending Aortic Distensibility (mmHg-1×10-3) .012 .11 0.6 0.44
Lean Mass Indexed to Height (g/m) .699 .84 120.6 <0.001Journal of Cardiovascular Magnetic Resonance 2009, 11:9 http://www.jcmr-online.com/content/11/1/9
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Pearson Correlations for Independent Predictors of Left Ventricular Mass Figure 2
Pearson Correlations for Independent Predictors of Left Ventricular Mass.Journal of Cardiovascular Magnetic Resonance 2009, 11:9 http://www.jcmr-online.com/content/11/1/9
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well known to cause left ventricular hypertrophy, neither
were independent predictors of left ventricular mass in a
multiple regression model. This is most likely explained
by the substantially greater effects of visceral fat mass,
stroke volume and lean body mass on the left ventricle.
In this study on simple linear regression analysis there was
again a statistically significant relationship between fast-
ing serum glucose and left ventricular mass. This could be
explained by the relationship between elevated fasting
serum glucose and elevated serum insulin, which has both
been linked to increased left ventricular mass and in this
study was associated with increased left ventricular mass
in this study. Interestingly, despite the documented link
between elevated CRP and left ventricular mass, in this
study there was no significant correlation between these
two variables. However, a recent study by Mehta et al
delineated that although LVH was associated with an
inflammatory state as reflected in elevated CRP levels
[37], this relationship appears to be mediated by comor-
bid conditions including hypertension, which was absent
from our cohort.
Limitations
The interpretation of multivariate analysis with multiple
independent variables must be done so in the context of
the relatively small nature of this study.
Conclusion
Obesity is linked to increased mortality. The mechanisms
behind this are poorly understood but may be related to
elevated left ventricular mass, which is independently
linked to mortality. As result of this, identification of the
determinants of left ventricular mass in obesity, has impli-
cations for prognosis and therapeutic intervention aimed
at reducing mortality. We have shown that lean body
mass, visceral fat mass, and stroke volume all have a sta-
tistically significant independent association with left ven-
tricular mass and together account for over 75% of the
variance in this study. This suggests that all three factors
play important roles in determining left ventricular mass
in obesity uncomplicated by co-morbidities.
Abbreviations
BMI: Body Mass Index; HOMA-IR: Homeostasis Model
Assessment: Insulin Resistance; CMR: Cardiovascular
Magnetic Resonance; SSFP: Steady State Free Procession;
TE: Echo Time; TR: Repetition Time; SD: Standard Devia-
tion.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
OR was involved in the design of the project, the data
acquisition, analysis and drafting of the manuscript. JB
was involved with patient recruitment, study design and
statistical methods. JF and MA were involved in the data
acquisition, and analysis SN, KC and SP conceived the
study, and participated in its design and coordination and
helped to draft the manuscript. All authors read and
approved the final manuscript.
Acknowledgements
The study was supported by a grant from the Wellcome Trust and by the 
Oxford Partnership Comprehensive Biomedical Research Centre with 
funding from the Department of Health's NIHR Biomedical Research Cen-
tres funding scheme.
References
1. Alpert MA: Obesity cardiomyopathy: pathophysiology and
evolution of the clinical syndrome.  Am J Med Sci 2001,
321:225-236.
2. Sutton-Tyrrell K, Newman A, Simonsick EM, Havlik R, Pahor M,
Lakatta E, Spurgeon H, Vaitkevicius P: Aortic stiffness is associ-
ated with visceral adiposity in older adults enrolled in the
study of health, aging, and body composition.  Hypertension
2001, 38:429-433.
3. Mattace-Raso FU, Cammen TJ van der, Hofman A, van Popele NM,
Bos ML, Schalekamp MA, Asmar R, Reneman RS, Hoeks AP, Breteler
MM, Witteman JC: Arterial stiffness and risk of coronary heart
disease and stroke: the Rotterdam Study.  Circulation 2006,
113:657-663.
4. Larsen GC, Griffith JL, Beshansky JR, D'Agostino RB, Selker HP: Elec-
trocardiographic left ventricular hypertrophy in patients
with suspected acute cardiac ischemia–its influence on diag-
nosis, triage, and short-term prognosis: a multicenter study.
J Gen Intern Med 1994, 9:666-673.
5. Levy D, Anderson KM, Savage DD, Kannel WB, Christiansen JC, Cas-
telli WP: Echocardiographically detected left ventricular
hypertrophy: prevalence and risk factors. The Framingham
Heart Study.  Ann Intern Med 1988, 108:7-13.
6. Vakili BA, Okin PM, Devereux RB: Prognostic implications of left
ventricular hypertrophy.  Am Heart J 2001, 141:334-341.
7. Adams KF, Schatzkin A, Harris TB, Kipnis V, Mouw T, Ballard-Barbash
R, Hollenbeck A, Leitzmann MF: Overweight, obesity, and mor-
tality in a large prospective cohort of persons 50 to 71 years
old.  N Engl J Med 2006, 355:763-778.
8. Savage DD, Levy D, Dannenberg AL, Garrison RJ, Castelli WP: Asso-
ciation of echocardiographic left ventricular mass with body
size, blood pressure and physical activity (the Framingham
Study).  Am J Cardiol 1990, 65:371-376.
9. Alexander JK: Obesity and the heart.  Heart Dis Stroke 1993,
2:317-321.
10. Ku CS, Lin SL, Wang DJ, Chang SK, Lee WJ: Left ventricular filling
in young normotensive obese adults.  Am J Cardiol 1994,
73:613-615.
11. Messerli FH: Cardiopathy of obesity–a not-so-Victorian dis-
ease.  N Engl J Med 1986, 314:378-380.
12. Perego L, Pizzocri P, Corradi D, Maisano F, Paganelli M, Fiorina P, Bar-
bieri M, Morabito A, Paolisso G, Folli F, Pontiroli AE: Circulating
leptin correlates with left ventricular mass in morbid (grade
III) obesity before and after weight loss induced by bariatric
surgery: a potential role for leptin in mediating human left
ventricular hypertrophy.  J Clin Endocrinol Metab 2005,
90:4087-4093.
13. Tajmir P, Ceddia RB, Li RK, Coe IR, Sweeney G: Leptin increases
cardiomyocyte hyperplasia via extracellular signal-regulated
kinase- and phosphatidylinositol 3-kinase-dependent signal-
ing pathways.  Endocrinology 2004, 145:1550-1555.
14. Rajapurohitam V, Gan XT, Kirshenbaum LA, Karmazyn M: The obes-
ity-associated peptide leptin induces hypertrophy in neona-
tal rat ventricular myocytes.  Circ Res 2003, 93:277-279.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Journal of Cardiovascular Magnetic Resonance 2009, 11:9 http://www.jcmr-online.com/content/11/1/9
Page 9 of 9
(page number not for citation purposes)
15. Abe Y, Ono K, Kawamura T, Wada H, Kita T, Shimatsu A, Hasegawa
K: Leptin induces elongation of cardiac myocyte and causes
eccentric left ventricular dilatation with compensation.  Am J
Physiol Heart Circ Physiol 2007, 292:H2387-96.
16. Myerson SG, Montgomery HE, World MJ, Pennell DJ: Left ventricu-
lar mass: reliability of M-mode and 2-dimensional echocardi-
ographic formulas.  Hypertension 2002, 40:673-678.
17. Wong C, Marwick TH: Obesity cardiomyopathy: pathogenesis
and pathophysiology.  Nat Clin Pract Cardiovasc Med 2007,
4:436-443.
18. Duncan MH, Singh BM, Wise PH, Carter G, Alaghband-Zadeh J: A
simple measure of insulin resistance.  Lancet 1995, 346:120-121.
19. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF,
Turner RC: Homeostasis model assessment: insulin resistance
and beta-cell function from fasting plasma glucose and insu-
lin concentrations in man.  Diabetologia 1985, 28:412-419.
20. Lintsi M, Kaarma H, Kull I: Comparison of hand-to-hand bioim-
pedance and anthropometry equations versus dual-energy
X-ray absorptiometry for the assessment of body fat per-
centage in 17–18-year-old conscripts.  Clin Physiol Funct Imaging
2004, 24:85-90.
21. Vasudev S, Mohan A, Mohan D, Farooq S, Raj D, Mohan V: Valida-
tion of body fat measurement by skinfolds and two bioelec-
tric impedance methods with DEXA–the Chennai Urban
Rural Epidemiology Study [CURES-3].  J Assoc Physicians India
2004, 52:877-81.
22. Wattanapenpaiboon N, Lukito W, Strauss BJ, Hsu-Hage BH, Wahl-
qvist ML, Stroud DB: Agreement of skinfold measurement and
bioelectrical impedance analysis (BIA) methods with dual
energy X-ray absorptiometry (DEXA) in estimating total
body fat in Anglo-Celtic Australians.  Int J Obes Relat Metab Dis-
ord 1998, 22:854-60.
23. Wiesmann F, Petersen SE, Leeson PM, Francis JM, Robson MD, Wang
Q, Choudhury R, Channon KM, Neubauer S: Global impairment
of brachial, carotid, and aortic vascular function in young
smokers: direct quantification by high-resolution magnetic
resonance imaging.  J Am Coll Cardiol 2004, 44:2056-2064.
24. Hudsmith LE, Petersen SE, Francis JM, Robson MD, Neubauer S: Nor-
mal human left and right ventricular and left atrial dimen-
sions using steady state free precession magnetic resonance
imaging.  J Cardiovasc Magn Reson 2005, 7:775-782.
25. Petersen SE, Wiesmann F, Hudsmith LE, Robson MD, Francis JM, Sel-
vanayagam JB, Neubauer S, Channon KM: Functional and struc-
tural vascular remodeling in elite rowers assessed by
cardiovascular magnetic resonance.  J Am Coll Cardiol 2006,
48:790-797.
26. Selvanayagam JB, Petersen SE, Francis JM, Robson MD, Kardos A,
Neubauer S, Taggart DP: Effects of off-pump versus on-pump
coronary surgery on reversible and irreversible myocardial
injury: a randomized trial using cardiovascular magnetic res-
onance imaging and biochemical markers.  Circulation 2004,
109:345-350.
27. Tintera J, Harantova P, Suchanek P, Dvorakova A, Adamova M, Hajek
M, Poledne R: Quantification of intra-abdominal fat during
controlled weight reduction: assessment using the water-
suppressed breath-hold MRI technique.  Physiol Res 2004,
53:229-234.
28. Kuch B, Schunkert H, Muscholl M, Doring A, von Scheidt W, Hense
HW: [Distribution, determinants and reference values of left
ventricular parameters in the general population–results of
the MONICA/KORA echocardiography studies].  Gesundheits-
wesen 2005, 67(Suppl 1):S68-73.
29. Silva EA, Flexa F, Zanella MT: Abdominal obesity, insulin resist-
ance and hypertension: impact on left ventricular mass and
function in women.  Arq Bras Cardiol 2007, 89:77-82.
30. Sukmoko S, Waspadji S, Alwi I, Nainggolan G: Correlation
between left ventricular mass and visceral fat thickness in
obese women.  Acta Med Indones 2006, 38:135-141.
31. Bella JN, Devereux RB, Roman MJ, O'Grady MJ, Welty TK, Lee ET,
Fabsitz RR, Howard BV: Relations of left ventricular mass to fat-
free and adipose body mass: the strong heart study. The
Strong Heart Study Investigators.  Circulation 1998,
98:2538-2544.
32. Morricone L, Malavazos AE, Coman C, Donati C, Hassan T, Caviezel
F: Echocardiographic abnormalities in normotensive obese
patients: relationship with visceral fat.  Obes Res 2002,
10:489-498.
33. Malavazos AE, Corsi MM, Ermetici F, Coman C, Sardanelli F, Rossi A,
Morricone L, Ambrosi B: Proinflammatory cytokines and car-
diac abnormalities in uncomplicated obesity: relationship
with abdominal fat deposition.  Nutr Metab Cardiovasc Dis 2007,
17:294-302.
34. Cittadini A, Stromer H, Katz SE, Clark R, Moses AC, Morgan JP,
Douglas PS: Differential cardiac effects of growth hormone
and insulin-like growth factor-1 in the rat. A combined in
vivo and in vitro evaluation.  Circulation 1996, 93:800-809.
35. Kupari M, Koskinen P, Virolainen J: Correlates of left ventricular
mass in a population sample aged 36 to 37 years. Focus on
lifestyle and salt intake.  Circulation 1994, 89:1041-1050.
36. Ganau A, Devereux RB, Pickering TG, Roman MJ, Schnall PL, Santucci
S, Spitzer MC, Laragh JH: Relation of left ventricular hemody-
namic load and contractile performance to left ventricular
mass in hypertension.  Circulation 1990, 81:25-36.
37. Mehta SK, Rame JE, Khera A, Murphy SA, Canham RM, Peshock RM,
de Lemos JA, Drazner MH: Left ventricular hypertrophy, sub-
clinical atherosclerosis, and inflammation.  Hypertension 2007,
49(6):1385-91.